What is Northland Capmk’s Estimate for inTEST Q2 Earnings?

inTEST Co. (NYSE:INTTFree Report) – Investment analysts at Northland Capmk lowered their Q2 2025 earnings estimates for shares of inTEST in a research note issued on Monday, March 10th. Northland Capmk analyst E. Jackson now anticipates that the company will post earnings of $0.03 per share for the quarter, down from their prior estimate of $0.08. Northland Capmk currently has a “Strong-Buy” rating on the stock. The consensus estimate for inTEST’s current full-year earnings is $0.41 per share. Northland Capmk also issued estimates for inTEST’s Q3 2025 earnings at $0.07 EPS and Q4 2025 earnings at $0.16 EPS.

Separately, Northland Securities lifted their target price on shares of inTEST from $13.00 to $16.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 8th.

Check Out Our Latest Analysis on inTEST

inTEST Price Performance

Shares of NYSE:INTT opened at $7.80 on Tuesday. The stock has a market cap of $96.53 million, a PE ratio of 33.91 and a beta of 1.90. The company’s fifty day moving average is $8.52 and its 200 day moving average is $7.78. inTEST has a 52 week low of $6.28 and a 52 week high of $14.35. The company has a quick ratio of 1.38, a current ratio of 2.26 and a debt-to-equity ratio of 0.08.

inTEST (NYSE:INTTGet Free Report) last posted its quarterly earnings data on Friday, March 7th. The company reported $0.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.14 by $0.09. inTEST had a net margin of 2.33% and a return on equity of 5.31%. During the same quarter in the prior year, the company posted $0.16 earnings per share.

Hedge Funds Weigh In On inTEST

A number of large investors have recently added to or reduced their stakes in INTT. Royce & Associates LP raised its position in inTEST by 9.9% in the 3rd quarter. Royce & Associates LP now owns 1,219,157 shares of the company’s stock worth $8,900,000 after purchasing an additional 110,078 shares during the period. Bard Associates Inc. raised its stake in shares of inTEST by 2.1% during the third quarter. Bard Associates Inc. now owns 199,170 shares of the company’s stock valued at $1,454,000 after acquiring an additional 4,105 shares during the last quarter. XTX Topco Ltd bought a new position in shares of inTEST during the third quarter valued at about $120,000. Geode Capital Management LLC raised its stake in shares of inTEST by 6.6% during the third quarter. Geode Capital Management LLC now owns 131,106 shares of the company’s stock valued at $957,000 after acquiring an additional 8,161 shares during the last quarter. Finally, JPMorgan Chase & Co. raised its stake in shares of inTEST by 42.1% during the third quarter. JPMorgan Chase & Co. now owns 37,481 shares of the company’s stock valued at $274,000 after acquiring an additional 11,102 shares during the last quarter. Hedge funds and other institutional investors own 63.18% of the company’s stock.

inTEST Company Profile

(Get Free Report)

inTEST Corporation provides test and process technology solutions for use in manufacturing and testing in automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets worldwide. The company operates through three segments: Electronic Test, Environmental Technologies, and Process Technologies.

See Also

Earnings History and Estimates for inTEST (NYSE:INTT)

Receive News & Ratings for inTEST Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for inTEST and related companies with MarketBeat.com's FREE daily email newsletter.